Flagship laboratory will feature one of the largest biorepositories in the world PISCATAWAY, N.J.–(BUSINESS WIRE)–Sampled1 has announced the expansion of its Sampled SMART Labs facility into a state-of-the-art, 140,000 square foot laboratory and biorepository in Piscataway, NJ. The biorepository will be one of the largest of its kind in the world, and construction is expected … [Read more…]
Poster presentation given by Harold Rabinovitz, M.D., Professor of Dermatology at the Medical College of Georgia in Augusta, Georgia FRIENDSWOOD, Texas–(BUSINESS WIRE)–$CSTL #CSTL–Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced a recent poster presentation showcasing the performance of its diagnostic gene expression profile (GEP) test, … [Read more…]
AVROBIO leading industry in combining use of two safety assays to evaluate genotoxicity risk prior to moving into clinical trials New safety assay uses machine learning algorithms and transcriptional profile data designed to assess the genotoxicity risk of integrating vectors CAMBRIDGE, Mass.–(BUSINESS WIRE)–$AVRO—AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company working to free … [Read more…]
CARLSBAD, Calif.–(BUSINESS WIRE)–#NASS–Carlsmed® announced today that the first patients have been enrolled in the COMPaSS™ study. COMPaSS, Clinical Outcome Measures in Personalized aprevo® Spine Surgery, is a multi-center post market prospective observational registry. The study will collect data on patients with degenerative spinal conditions and are treated surgically with Carlsmed aprevo devices and will track … [Read more…]
Second registration study of Tyvaso® (treprostinil) Inhalation Solution for patients with IPF SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that the first patient has enrolled in the phase 3 TETON 2 study which will evaluate Tyvaso in 396 adult patients with idiopathic pulmonary … [Read more…]
Experienced government and external affairs leader with a 20+ year track record of making an impact at the intersection of innovation, business and policy NEW YORK–(BUSINESS WIRE)–LetsGetChecked, a global healthcare solutions company, announced today that it has appointed Kathleen Lynch as Senior Vice President of Global Government Affairs. In the newly created role, Lynch will … [Read more…]
Third quarter 2022 core lung diagnostic testing revenues growth up 96% to 103% compared to third quarter 2021 BOULDER, Colo.–(BUSINESS WIRE)–$BDSX #patientsfirst–Biodesix, Inc. (NASDAQ: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that the Company expects to report third quarter 2022 total revenue to be in the range … [Read more…]
Highly complementary spine and orthopedics portfolios One of the industry’s broadest biologics and regenerative technology offerings Differentiated and synergistic enabling technologies Meaningful cross-selling revenue synergies and cost savings Financial strength to pursue growth investments without need for immediate equity financing Expected to be adjusted EBITDA accretive to Orthofix by the second year following close including … [Read more…]
BOSTON & ST. LOUIS–(BUSINESS WIRE)–Omniose, a company developing polysaccharide conjugate vaccines against serious bacterial threats, has been awarded a $3.6 million grant for the development of a Klebsiella pneumoniae vaccine from the National Institute of Allergy and Infectious Diseases of the U.S. National Institutes of Health. Klebsiella pneumoniae is a leading cause of life-threatening sepsis … [Read more…]
– Newly established Focal Biosciences will focus on bringing together leading experts and scientific discoveries to harness cellular reprogramming in the fight against common age-related diseases BOSTON & BERLIN & VILLIGEN, Switzerland–(BUSINESS WIRE)–Apollo Health Ventures and the Paul Scherrer Institute (PSI) launched Focal Biosciences. The newly established biotech company aims to redefine the treatment of … [Read more…]
